rawfin.tv
Citi Group Entities Cease Substantial Holder Status in Telix Pharmaceuticals
MarketsstocksAI Generated

Citi Group Entities Cease Substantial Holder Status in Telix Pharmaceuticals

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Citigroup Global Markets Australia and its affiliated entities have announced they are no longer a substantial holder in Telix Pharmaceuticals. This change reflects a reduction in their ownership stake in the pharmaceutical company.

CTelix PharmaceuticalsInstitutional OwnershipPortfolio ChangesHealthcare

Related Articles

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks
EQT to Acquire Cleanaway Waste for $6.5 Billion

EQT to Acquire Cleanaway Waste for $6.5 Billion

stocks
S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

stocks
US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

stocks